Cargando…
Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report
Basidiobolomycosis is an opportunistic fungal infection with a high morbidity and mortality rate. It is known to cause invasive disease in immunocompromised persons but it may produce only cutaneous or subcutaneous infections in an immunocompetent patient. Treatment is difficult due to its fulminant...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809181/ https://www.ncbi.nlm.nih.gov/pubmed/35198478 http://dx.doi.org/10.4103/idoj.IDOJ_741_20 |
_version_ | 1784643969597046784 |
---|---|
author | Chaudhari, Dixit G. Jagati, Ashish Chaudhary, Raju G. Shah, Malhar J. |
author_facet | Chaudhari, Dixit G. Jagati, Ashish Chaudhary, Raju G. Shah, Malhar J. |
author_sort | Chaudhari, Dixit G. |
collection | PubMed |
description | Basidiobolomycosis is an opportunistic fungal infection with a high morbidity and mortality rate. It is known to cause invasive disease in immunocompromised persons but it may produce only cutaneous or subcutaneous infections in an immunocompetent patient. Treatment is difficult due to its fulminant course and lack of effective anti-fungal drugs. But here, we report a rare case of Basidiobolomycosis detected in an immunocompetent patient—without any debilitating illness, which showed a complete response to itraconazole 200 mg daily without any surgical intervention. |
format | Online Article Text |
id | pubmed-8809181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-88091812022-02-22 Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report Chaudhari, Dixit G. Jagati, Ashish Chaudhary, Raju G. Shah, Malhar J. Indian Dermatol Online J Case Report Basidiobolomycosis is an opportunistic fungal infection with a high morbidity and mortality rate. It is known to cause invasive disease in immunocompromised persons but it may produce only cutaneous or subcutaneous infections in an immunocompetent patient. Treatment is difficult due to its fulminant course and lack of effective anti-fungal drugs. But here, we report a rare case of Basidiobolomycosis detected in an immunocompetent patient—without any debilitating illness, which showed a complete response to itraconazole 200 mg daily without any surgical intervention. Wolters Kluwer - Medknow 2022-01-24 /pmc/articles/PMC8809181/ /pubmed/35198478 http://dx.doi.org/10.4103/idoj.IDOJ_741_20 Text en Copyright: © 2022 Indian Dermatology Online Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Chaudhari, Dixit G. Jagati, Ashish Chaudhary, Raju G. Shah, Malhar J. Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report |
title | Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report |
title_full | Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report |
title_fullStr | Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report |
title_full_unstemmed | Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report |
title_short | Subcutaneous Basidiobolomycosis Treated Successfully with Oral Itraconazole: A Case Report |
title_sort | subcutaneous basidiobolomycosis treated successfully with oral itraconazole: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809181/ https://www.ncbi.nlm.nih.gov/pubmed/35198478 http://dx.doi.org/10.4103/idoj.IDOJ_741_20 |
work_keys_str_mv | AT chaudharidixitg subcutaneousbasidiobolomycosistreatedsuccessfullywithoralitraconazoleacasereport AT jagatiashish subcutaneousbasidiobolomycosistreatedsuccessfullywithoralitraconazoleacasereport AT chaudharyrajug subcutaneousbasidiobolomycosistreatedsuccessfullywithoralitraconazoleacasereport AT shahmalharj subcutaneousbasidiobolomycosistreatedsuccessfullywithoralitraconazoleacasereport |